Evaluation of small extracellular vesicles as biomarkers of efficacy with anti-PD-1 mAb therapy in patients with recurrent/metastatic HNSCC. Abemaciclib in recurrent/metastatic head and neck squamous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results